Practice Management News

On July 24, President Donald Trump signed four executive orders intended to curb skyrocketing drug prices in the United States — notable among them was the plan to match prices for certain Medicare drugs to those offered in other countries.

Nurses continue to face substantial challenges more than 6 months into the COVID-19 pandemic, particularly with access to PPE.

The use of corticosteroids improved the odds that adults who are critically ill with COVID-19 would survive, according to data from four studies recently published in JAMA.

Less than 4% of about 3,400 close contacts of people with COVID-19 in the early days of the pandemic in China were infected with SARS-CoV-2, researchers wrote in Annals of Internal Medicine.

The American Academy of Sleep Medicine has issued a position statement seeking the elimination of daylight saving time, citing the unhealthy and sometimes deadly consequences of it.

State laws regarding generic drug and interchangeable biologic substitutions vary widely in the United States, researchers reported.

By 2040, researchers predict 75% of cirrhosis cases in North America will be due to nonalcoholic fatty liver disease with a nearly 350% increase in women born after 1980, according to a presenter at the Digital International Liver Conference.

Though absolute differences did not emerge in the treatment of hepatic encephalopathy with L-carnitine, a presenter at the Digital International Liver Congress suggested the changes seen indicate more research with higher doses may be warranted.

HHS recently announced its Healthy People 2030 initiative to address what the agency called the “most critical public health priorities and challenges” in the United States over the next decade.

President Donald J. Trump’s recent executive order to ensure the production of essential medicines in the United States and cut down on the country’s reliance on foreign production of medical supplies drew mixed reactions from experts.